AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 291 filers reported holding AVANOS MED INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | 0.0% | 319 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | +10.0% | 319 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $10,000 | -16.7% | 319 | -0.6% | 0.00% | -25.0% |
| Q2 2021 | $12,000 | -14.3% | 321 | +0.6% | 0.00% | -20.0% |
| Q1 2021 | $14,000 | +7.7% | 319 | +10.4% | 0.01% | -16.7% |
| Q4 2020 | $13,000 | +30.0% | 289 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $10,000 | +25.0% | 289 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $8,000 | 0.0% | 289 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $8,000 | -20.0% | 289 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $10,000 | -9.1% | 289 | -3.7% | 0.01% | -14.3% |
| Q3 2019 | $11,000 | -15.4% | 300 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $13,000 | 0.0% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $13,000 | 0.0% | 300 | 0.0% | 0.01% | -11.1% |
| Q4 2018 | $13,000 | -27.8% | 300 | 0.0% | 0.01% | -25.0% |
| Q3 2018 | $18,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |